99.0%
HPLC Verified
COA
Available
ISO
Certified Lab
AOD-9604
Fat-targeting fragment without growth hormone side effects
5mg vial | 5mg/vial
About AOD-9604
AOD-9604 is a synthetic peptide analog of the lipolytic region of human growth hormone. By isolating the fat-burning portion of hGH (amino acids 176-191) and adding a stabilizing tyrosine, researchers created a compound that promotes fat breakdown without affecting blood sugar or growth.
Unlike full growth hormone, AOD-9604 does not compete for the hGH receptor in ways that increase IGF-1 or cause insulin resistance. This makes it a compelling option for those seeking targeted fat reduction as part of a comprehensive weight management strategy.
Studies have shown it triggers the release of fat from obese fat cells while reducing the accumulation of new fat. It has received GRAS (Generally Recognized As Safe) status from the FDA for use as a food supplement ingredient.
Key Benefits
Published Research
Phase 2b clinical trial showed significant reduction in body fat in obese subjects over 12 weeks. AOD-9604 received FDA GRAS status (GRN 000620). No adverse effects on glucose tolerance, IGF-1 levels, or bone growth observed.
View Full Research LibraryRelated Products
Semaglutide
The gold standard in GLP-1 weight management
Tirzepatide
Dual-action GIP/GLP-1 for maximum results
Liraglutide
The proven GLP-1 pioneer with years of clinical data